FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072843 [Registered on: 21/08/2024] Trial Registered Prospectively
Last Modified On: 19/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   Comparison of plain ropivacaine and ropivacaine with adjuvants in different participants undergoing chest surgeries and assessment of post operative pain as the main outcome 
Scientific Title of Study   A prospective observational study to assess post operative analgesia following addition of dexmeditomidine or dexamethasone to ropivacaine in erector spinae plane block in children undergoing thoracic surgeries  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Tarannum Shaikh  
Designation  Junior resident doctor  
Affiliation  LOKMANYA TILAK MUNCIPAL MEDICAL COLLEGE AND HOSPITAL 
Address  FLAT 313 THIRD FLOOR GANDHI MARKET SION WEST MUMBAI DEPARTMENT OF ANAESTHESIOLOGY, LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND HOSPITAL, MUMBAI

Mumbai
MAHARASHTRA
400022
India 
Phone  7219510997  
Fax    
Email  tanno999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anila D Malde  
Designation  Head of department of Anaesthesiology  
Affiliation  Lokmanya Tilak municipal medical college and general hospital  
Address  4th floor , department of anaesthesiology, Lokmanya Tilak municipal medical college and hospital , Sion West, Mumbai

Mumbai
MAHARASHTRA
400022
India 
Phone  9821085730  
Fax    
Email  dradmalde@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Tarannum Shaikh  
Designation  Junior resident doctor 
Affiliation  Lokmanya Tilak municipal medical college and general hospital  
Address  FLAT 313 THIRD FLOOR GANDHI MARKET SION WEST MUMBAI, DEPARTMENT OF ANAESTHESIOLOGY, LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND HOSPITAL

Mumbai
MAHARASHTRA
400022
India 
Phone  7219520997  
Fax    
Email  tanno999@gmail.com  
 
Source of Monetary or Material Support  
Lokmanya Tilak Municipal medical college and hospital , Sion West Mumbai 400022 
 
Primary Sponsor  
Name  Lokmanya Tilak Municipal Medical college and Hospital 
Address  Lokmanya Tilak Municipal medical college and hospital, Sion west Mumbai 40022 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Tarannum Shaikh   Lokmanya Tilak municipal medical college   N424, 4th floor , department of anaesthesiology Lokmanya Tilak municipal medical college and hospital , sion , Mumbai 400022
Mumbai
MAHARASHTRA 
7219520997

tanno999@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee human research lokmanya tilak municipal medical college and muncicpal hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  6.00 Month(s)
Age To  18.00 Year(s)
Gender  Both 
Details  All the children between the age group of 6 months to 18 years who have received general endotracheal anaesthesia plus Erector spinae plane block for open thoracic surgeries or VATS using plain ropivacaine or ropivacaine with adjuvants.  
 
ExclusionCriteria 
Details  1.Patients who are in altered sensorium
2.Patients who are already sedated or on ventilatory support since visual analog score (VAS) or FLACC score cannot be checked in them  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study and compare the duration of post operative analgesia following addition of dexamethasone ( 0.15 mg/kg) or dexmedetomidine ( 1mcg/kg) to ropivacaine versus plain ropivacaine in ESPB following thoracic surgeries ( open /VATS)   The post operative pain score would be assessed 3 hours 12 hours, 24 hours and 36 hours after the procedure 
 
Secondary Outcome  
Outcome  TimePoints 
To compare and assess the following in the group R (plain ropivacaine 0.4ml/kg of 0.5% ropivacaine), group RD (0.4ml/kg of 0.5% ropivacaine + 0.15 mg/kg dexamethasone) and group RDM (0.4ml/kg 0f 0.5% ropivacaine + 1 µg/kg dexmedetomidine)
1. The requirement of intra operative analgesic
2. The number of rescue analgesics required in first 24 hours
3. Parental satisfaction  
To assess the number of intra op rescue analgesics required and to assess post op PAIN score  
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Thoracic surgeries like decortications can be done by either open approach or as video assisted thoracoscopic surgeries (VATS)Thoracotomy surgeries which involve stripping of pleura can give rise to significant pain. Adequate analgesia while recovering from thoracic surgeries is essential for providing patient comfort and preventing complications such as pneumonia and respiratory failure.

The erector spinae plane block (ESPB), first described by anaesthesiologist Mauricio Forero in 2016 is a multi-dermatomal sensory block that provides regional anaesthesia to the ipsilateral chest wall. The site of action is the dorsal and ventral rami of the thoracic nerves, typically extending from the level of T3 to T10. It has been tried for analgesia in thoracic, surgical and chest trauma patients, providing excellent pain relief while reducing narcotic requirementsThe ESPB does not pose risk of direct neurological injury and can be placed when the patient is anaesthetized. 
In this study patients undergoing thoracic surgeries who receive general endotracheal anaesthesia and erector spinae plane block (ESPB) will be observed. Patient is taken inside the operation theatre , all the monitors are attached and general endotracheal anaesthesia is given using injection propofol 3mg/kg or inhalational sevoflurane. Non depolarising muscle relaxant is given . All patients receive injection fentanyl 2mcg/kg.
  Patient is given lateral decubitus position and ESPB is given  between T5/T6 transverse process and erector spinae muscle using either plain ropivacaine ( group R- 0.4ml/kg of 0.5% ropivacaine or ropivacaine with adjuvants ( group RD 0.15mg/kg or group RDM 1mcg/kg dexmeditomidine ). 
Intra operatively the patient is monitored and if there is increase in  pain stimuli in the form of increase in heart rate or systolic blood pressure by 20% then rescue analgesic injection fentanyl 0.5 mcg/kg is given and noted
.After extubation the patient is observed in recovery room for 3 hours and if  post operative pain score (VAS score or FLACC)  is >3 injection fentanyl 0.5mcg/kg is given and noted. After 3 hours the patient is shifted to ward and if the pain still perssits injection paracetamol 15mg/kg is given and any other complications if present are noted. 





 
Close